Although high concentrations of antidepressants and mood stabilizers work on TREK channels in vitro, the TREK-1 channel could not be excluded from an effective target for mood disorders, including bipolar disorder and depression, in vivo. Here, KCNK2 is linked to depressive symptom measurement.